Metabolic dysfunction-associated fatty liver disease and atherosclerotic cardiovascular disease risk: Dual aetiology or metabolic dysfunction?

被引：1
作者：
Ma, Tianyi [1 ]
Yuan, Huawei [1 ]
Guo, Zhanfang [1 ]
机构：
[1] Dalian Univ Technol, Cent Hosp, Dept Gastroenterol & Hepatol, Dalian, Peoples R China
来源：
LIVER INTERNATIONAL | 2024年 / 44卷 / 11期
关键词：
D O I：
10.1111/liv.16082
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：3103 / 3104
页数：2
相关论文
共 50 条
  • [21] The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease
    Barrera, Francisco
    Uribe, Javier
    Olvares, Nixa
    Huerta, Paula
    Cabrera, Daniel
    Romero-Gomez, Manuel
    ANNALS OF HEPATOLOGY, 2024, 29 (04)
  • [22] Association of metabolic dysfunction-associated fatty liver disease with kidney disease
    Wang, Ting-Yao
    Wang, Rui-Fang
    Bu, Zhi-Ying
    Targher, Giovanni
    Byrne, Christopher D.
    Sun, Dan-Qin
    Zheng, Ming-Hua
    NATURE REVIEWS NEPHROLOGY, 2022, 18 (04) : 259 - 268
  • [23] Metabolic dysfunction-associated fatty liver disease increases cardiovascular risk regardless of classical risk factors
    Del Barrio Azaceta, Maria
    Iruzubieta, Paula
    Aller De La Fuente, Rocio
    Maria Banales, Jesus
    Santos-Laso, Alvaro
    Calleja Panero, Jose Luis
    Ibanez, Luis
    Arias Loste, Maria Teresa
    Romero Gomez, Manuel
    Garcia-Monzon, Carmelo
    Gomez-Camarero, Judith
    Gines, Pere
    Morillas, Rosa M.
    Manuel Pericas, Juan
    Aspichueta, Patricia
    Martin-Mateos, Rosa
    Gallego-Duran, Rocio
    De La Torre Sanchez, Mercedes
    Escudero-Garcia, Desamparados
    Bernal Monterde, Vanesa
    Benlloch, Salvador
    Turnes, Juan
    Crespo, Javier
    JOURNAL OF HEPATOLOGY, 2022, 77 : S157 - S157
  • [24] Cardiovascular Disease Risk Is Increased In Adolescents With Metabolic Dysfunction-associated Steatotic Liver Disease
    Short, Kevin R.
    Palle, Sirish K.
    Tryggestad, Jeanie B.
    Hellman, Diana A.
    Sciarrillo, Christina M.
    Emerson, Sam R.
    Friedman, Jacob E.
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2024, 56 (10) : 680 - 680
  • [25] Therapeutics for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
    Bhopale, Kamlesh K.
    Srinivasan, Mukund P.
    LIVERS, 2023, 3 (04): : 597 - 617
  • [26] Ferroptosis and metabolic dysfunction-associated fatty liver disease: Is there a link?
    Feng, Gong
    Byrne, Christopher D.
    Targher, Giovanni
    Wang, Fudi
    Zheng, Ming-Hua
    LIVER INTERNATIONAL, 2022, 42 (07) : 1496 - 1502
  • [27] Metabolic dysfunction-associated fatty liver disease: a year in review
    Alharthi, Jawaher
    Gastaldelli, Amalia
    Cua, Ian Homer
    Ghazinian, Hasmik
    Eslam, Mohammed
    CURRENT OPINION IN GASTROENTEROLOGY, 2022, 38 (03) : 251 - 260
  • [28] Cardiometabolic characterization in metabolic dysfunction-associated fatty liver disease
    Perdomo, Carolina M.
    Nunez-Cordoba, Jorge M.
    Ezponda, Ana
    Mendoza, Francisco J.
    Ampuero, Javier
    Bastarrika, Gorka
    Fruhbeck, Gema
    Escalada, Javier
    FRONTIERS IN MEDICINE, 2022, 9
  • [29] The Efficacy of Tofogliflozin on Metabolic Dysfunction-Associated Fatty Liver Disease
    Goya, Takeshi
    Imoto, Koji
    Tashiro, Shigeki
    Aoyagi, Tomomi
    Takahashi, Motoi
    Kurokawa, Miho
    Suzuki, Hideo
    Tanaka, Masatake
    Kato, Masaki
    Kohjima, Motoyuki
    Ogawa, Yoshihiro
    GASTROENTEROLOGY INSIGHTS, 2022, 13 (01) : 20 - 26
  • [30] Metabolic Dysfunction-Associated Steatotic Liver Disease vs. Metabolic Dysfunction-Associated Fatty Liver Disease: Which Option is the Better Choice?
    Gambardella, Maria Luisa
    Abenavoli, Ludovico
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2025, 86 (02)
12345